CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980597776
- Phone
- 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-14 | McElhaugh Michael J. Chief Business Officer | Sale | −10,000 | $5.00 | $50K | 1,327,457 |
| 2020-09-23 | Picchio Gaston Chief Development Officer | Grant or award · Common Stock | +50,000 | 50,000 | ||
| 2020-09-23 | Collier William H. President and CEO | Grant or award · Stock Options | +70,000 | 70,000 | ||
| 2020-07-23 | McElhaugh Michael J. Chief Business Officer | Sale | −20,000 | $5.01 | $100K | 1,367,457 |
| 2020-05-28 | Meyers James R Director | Grant or award · Stock Options | +22,000 | 22,000 | ||
| 2020-05-28 | HENRIQUES RICHARD C JR Director | Grant or award · Stock Options | +22,000 | 22,000 | ||
| 2020-05-28 | Collier William H. President and CEO | Grant or award · Stock Options | +262,313 | 262,313 | ||
| 2020-05-28 | Torti Frank Director | Grant or award · Stock Options | +22,000 | 22,000 | ||
| 2020-05-28 | Cheng Andrew Director | Grant or award · Stock Options | +22,000 | 22,000 | ||
| 2020-05-28 | MANCHESTER KEITH S Director | Grant or award · Stock Options | +22,000 | 22,000 | ||
| 2020-05-28 | BURGESS DANIEL D Director | Grant or award · Stock Options | +22,000 | 22,000 | ||
| 2020-02-17 | Howard Elizabeth Chief Compliance Officer | Grant or award · Stock Options | +79,500 | 79,500 | ||
| 2020-02-17 | Sofia Michael J. Chief Scientific Officer | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2020-02-17 | Picchio Gaston Chief Development Officer | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2020-02-17 | Collier William H. President and CEO | Grant or award · Stock Options | +367,087 | 367,087 | ||
| 2020-02-17 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2020-02-17 | McElhaugh Michael J. Chief Business Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2019-08-17 | Cheng Andrew Director | Grant or award · Stock Options | +60,000 | 60,000 | ||
| 2019-08-17 | POTTER MYRTLE S Director | Grant or award · Stock Options | +22,000 | 22,000 | ||
| 2019-08-17 | BURGESS DANIEL D Director | Grant or award · Stock Options | +22,000 | 22,000 |
Page 7 of 8 · 141 trades